The treatment of fever and neutropenia following chemotherapy lends itself
well to outpatient parenteral antimicrobial therapy (OPAT). Patients prefer
to be at home rather than hospitalized again. There is a clear cost advant
age of outpatient therapy. With a quality program and careful patient selec
tion, OPAT can be provided effectively and safely. The chances of an infect
ion due to resistant bacteria also appear to be reduced. There are an incre
asing number of studies that support the use of empiric antibiotic therapy
for the first fever in neutropenic patients. The choice of antimicrobial, d
ose, as well as vascular access and infusion devices must be tailored to th
e individual patient needs and circumstances.